Saccharomyces cerevisiae donor preference during mating-type switching is dependent on chromosome architecture and organization.

Genetics
Eric CoïcJames E Haber

Abstract

Saccharomyces mating-type (MAT) switching occurs by gene conversion using one of two donors, HMLalpha and HMRa, located near the ends of the same chromosome. MATa cells preferentially choose HMLalpha, a decision that depends on the recombination enhancer (RE) that controls recombination along the left arm of chromosome III (III-L). When RE is inactive, the two chromosome arms constitute separate domains inaccessible to each other; thus HMRa, located on the same arm as MAT, becomes the default donor. Activation of RE increases HMLalpha usage, even when RE is moved 50 kb closer to the centromere. If MAT is inserted into the same domain as HML, RE plays little or no role in activating HML, thus ruling out any role for RE in remodeling the silent chromatin of HML in regulating donor preference. When the donors MAT and RE are moved to chromosome V, RE increases HML usage, but the inaccessibility of HML without RE apparently depends on other chromosome III-specific sequences. Similar conclusions were reached when RE was placed adjacent to leu2 or arg4 sequences engaged in spontaneous recombination. We propose that RE's targets are anchor sites that tether chromosome III-L in MATalpha cells thus reducing its mobility in the nucleus.

References

Jan 1, 1992·Current Genetics·D C ChenT T Kuo
Jan 1, 1987·Methods in Enzymology·J D BoekeG R Fink
Mar 1, 1982·Cell·A J KlarJ N Strathern
Jun 17, 1994·Science·S Loo, J Rine
Nov 19, 1993·Cell·L L Sandell, V A Zakian
Oct 7, 2003·Annual Review of Biochemistry·David L Spector
Nov 25, 2003·Science·Martin ThompsonDavid R Engelke
Jan 28, 2004·The Journal of Cell Biology·Debra A BressanJames E Haber
Dec 1, 2004·Annual Review of Genetics·Angela TaddeiSusan M Gasser
Dec 1, 1949·Journal of Genetics·D E LEA, C A COULSON

❮ Previous
Next ❯

Citations

Dec 3, 2008·Molecular and Cellular Biology·Kerstin BystrickySusan M Gasser
Mar 26, 2013·Molecular Cell·Jörg RenkawitzStefan Jentsch
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Barış AvşaroğluJane Kondev
May 16, 2014·Nature Reviews. Molecular Cell Biology·Jörg RenkawitzStefan Jentsch
May 10, 2017·Genetics·Sara J Hanson, Kenneth H Wolfe
Jun 25, 2015·Microbiology Spectrum·Cheng-Sheng Lee, James E Haber

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.